Rick Matthews: Cancer-Associated VTE Mortality and the Need for Coordinated Care
Rick Matthews, Sr. Vascular Consultant at Argon Medical Devices, Inc, Radiology Instructor at Pima Medical Institute, shared a post on LinkedIn about a recent article by Gang Li et al, published in Journal of Thrombosis and Thrombolysis, adding:
“This week’s VTE literature reinforces an important point: effective VTE care extends well beyond the procedure.
A new analysis of more than 312,000 VTE-related deaths among U.S. adults with cancer found that the age-adjusted mortality rate increased by 93.4 percent between 1999 and 2024.
Although the study does not evaluate thrombectomy or establish causation, it highlights the need for stronger oncology-focused VTE pathways—including early recognition, standardized risk assessment, appropriate anticoagulation, timely referral, and structured follow-up.
A second publication focused on IVC filter selection, complications, removal, and the risks associated with prolonged dwell time.
One of the most practical takeaways is that filter placement should be treated as part of a longitudinal care pathway—not as an isolated procedure.
Every filter pathway should clearly identify:
- Why the filter was placed
- Whether the anticoagulation contraindication is temporary or permanent
- Who owns follow-up
- When the patient will be reassessed
- Whether and when retrieval should occur
The broader lesson is clear: successful VTE programs require coordinated patient identification, thoughtful treatment selection, documented follow-up ownership, and meaningful outcome measurement.
Technology matters—but the pathway surrounding that technology ultimately determines whether patients receive timely, coordinated care.”
Title: Venous thromboembolism mortality trends among us adults with cancer, 1999–2024
Authors: Gang Li, Xue Zhang, Guanbo Zhang, Jinsong Li, Jiaxing Wang, Zhijian Chen, Qingbin Zeng
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 16, 2026, 10:30Danny Gaskin: Transfusion Practitioners at the Heart of Maternity and Anti-D Care
-
Sep 16, 2026, 10:15Massimiliano Camilli: Mechanistic Insights Into Cardiovascular Risk Across Androgen Deprivation Therapies
-
Sep 16, 2026, 09:57Nathan Connell: A Regional Approach to Advancing Contemporary Hemophilia A Care
-
Sep 16, 2026, 09:20Mengistu Abate Belay: Bridging the Gap in Anemia Prevention During Pregnancy
-
Sep 16, 2026, 09:09Younes Kalakhy: When Normal Coagulation Tests Miss von Willebrand Disease
-
Sep 16, 2026, 09:00Test Your Knowledge of Warm Autoimmune Hemolytic Anemia – ASH Education
-
Sep 16, 2026, 08:28Jean Nakhle: Uncovering How Excess Cysteine Drives Cell Death
-
Sep 16, 2026, 08:20Heghine Khachatryan: Arterial and Venous Thrombosis May Require Different Approaches in Neonates
-
Sep 16, 2026, 07:57Tammuella Chrisentery-Singleton: Standing on the Shoulders of Giants in Hemophilia Care